Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin for BK Virus Prevention in Renal Transplant
NCT01789203Phase 4Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- Jan 2013
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in BK virus infection comparing Ciprofloxacin with Placebo (2 arms). Primary endpoint: Number of Patients Developing BK Infection at 6 Months Post-transplant. Started Jan 2013; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
BK virus infection
Beyond the preview
Go deeper on NCT01789203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01789203.